New PET imaging biomarker Gal-1 predicts tumor responses to immunotherapy

FHS
May 15, 2024
4:42 pm

The protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing physicians to predict the tumor responses before beginning treatment.

Do vegetarian diets improve the cardiometabolic profile of people with or at high risk of cardiovascular diseases?

The role of vegetarian diets in promoting glycemic control and weight changes in the prevention and management of cardiovascular diseases.

August 1, 2023

Which pharmacotherapies are associated with improved outcomes for people with alcohol use disorder?

Researchers assessed the efficacy and compared the relative effectiveness of various pharmacological treatments for alcohol use disorder.

November 8, 2023

Innovative nanoparticle therapy enhances recovery in severe burn patients

Severe burns can cause critical issues, including deep tissue damage and increased risk of fatal conditions like sepsis and organ failure.

March 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.